Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers extends lead with new Opdivo indication
Bristol-Myers extends lead with new Opdivo indication
Bristol-Myers extends lead with new Opdivo indication
Submitted by
admin
on May 17, 2016 - 5:20pm
Source:
BioPharma Dive
News Tags:
Bristol-Myers Squibb
Opdivo
Hodgkin's lymphoma
FDA
Headline:
Bristol-Myers extends lead with new Opdivo indication
Do Not Allow Advertisers to Use My Personal information
